Half of men experience erectile dysfunction (ED) by age 50, yet the medical field continues to rely largely on patient’s subjective reports for diagnosis and treatment. FirmTech has redefined this outdated approach with TechRing, a smart and comfortable wearable device that provides objective, actionable, and individualized data to men and their healthcare providers. By incorporating measurable insights into assessing sexual health, FirmTech empowers men to make informed decisions and improve clinical outcomes.

A Paradigm Shift in Sexual Medicine

In most medical disciplines, data from devices guides diagnosis and management, like blood pressure tools, electrocardiograms, glucose monitors, and digital pulse oximeters. However, men’s sexual health often relies on anecdotal reports, leaving a significant gap in effective care.

“This reliance on subjective input limits doctors’ ability to design precise treatment plans and undermines patient outcomes,” explains Dr. Elliot Justin, FirmTech’s CEO. “Erection pills, expensive therapies like testosterone and shock therapy, and even procedures are recommended without data for establishing baselines and tracking the impact of interventions. Will it work? How well is it working? Is it worth the cost?”

FirmTech bridges this gap by delivering measurable, detailed insights into sex and nocturnal erections. “How hard are they, how long do they last? Frequency? How do one man’s compare to norms for his age and conditions? Doctors would never prescribe antihypertensives or antiarrhythmics without objective data. Why should sexual health be any different?” notes Dr. Justin.

The Science Behind the TechRing

TechRing operates at the intersection of cutting-edge engineering and sexual medicine. Designed for comfort and ease of use, the device captures key erection data while being discreet and non-invasive. This data equips users and clinicians with an Erectile Fitness Score, offering unprecedented clarity in assessing sexual health.

The device works by using medical-grade sensors that measure changes in circumference and firmness. These metrics are essential in detecting vascular, neurological, medication-related, or performance anxiety issues that often underlie ED. For example, reduced nocturnal erections may signal underlying cardiovascular disease or early diabetes, conditions that often remain unnoticed until advanced stages. The TechRing translates raw data into actionable insights, allowing for earlier intervention and more personalized care.

FirmTech is also pushing the envelope with its upcoming TechRing 2.0. This next-generation device will analyze additional parameters like pulse amplitude, rhythm, precise girth, sexual positions, and even estimate caloric burn. This additional data will further integrate sexual health into broader preventive medicine.

Beyond Erectile Function

The TechRing’s utility also goes far beyond monitoring erections. Its ability to track nocturnal patterns provides critical insights into vascular and nerve health, key indicators of broader health conditions. By offering a real-time connection between lifestyle factors — such as sleep, stress, and exercise, not to mention sexual wellness, the TechRing encourages users to adopt healthier habits. This holistic view bridges the gap between sexual health and overall wellness, making it a tool for preventive care, not just a diagnostic aid.

Market Opportunity and Expansion

FirmTech’s data-first approach aligns with the increasing demand for technology-driven health solutions, particularly among men over 45 seeking proactive approaches to longevity and wellness. The company anticipates annual sales of 100,000 units by 2027, translating to $40 million in revenue.

Additionally, FirmTech is extending its expertise into women’s health with the development of the Clitique, a product designed to provide equally precise insights into female sexual wellness by monitoring clitoral health. By addressing gaps in care for all genders, FirmTech is on its way to becoming a leader in sexual health innovation.

Advancing Research for Real-world Impact

FirmTech’s research and development efforts support credibility: 45,000 erections documented, six papers published or accepted, and 15 more projects approved or underway. The data from the Tech Ring is reshaping how ED and related conditions are understood and treated, and the evidence supports the case for insurance coverage in 2025. 

“Sexual health practitioners can make smarter decisions that will also be more cost-effective than the current “shotgun” approach,” explains Dr. Justin. “Decision-making without data will be replaced by data-driven care that is individualized, as opposed to “one size fits all” of current practice.”

With its TechRing and forthcoming innovations, the company is enhancing intimacy, improving health outcomes, and elevating sexual performance for all. FirmTech’s commitment to precision, accessibility, and preventive care represents a new standard for sexual health. He also predicts that within a few years, many common misconceptions about ED will be dismantled thanks to the insights generated by FirmTech’s science-backed Medtech devices.

To learn more about FirmTech and its cutting-edge solutions, go to the company website.